Henry Schein, Inc. (HSIC)
87.65
+0.35
(+0.40%)
USD |
NASDAQ |
Sep 11, 14:41
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 9.809B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 29.51% |
| Valuation | |
| PE Ratio | 25.54 |
| PE Ratio (Forward) | |
| PS Ratio | 0.7569 |
| Price to Book Value | 3.107 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.208 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 32.70% |
Profile
| Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the following segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The Global Distribution and Value-Added Services segment focuses on distribution to the global dental and medical markets of national brand and corporate brand merchandise, and equipment and related technical services. The Global Specialty Products segment includes manufacturing, marketing and sales of dental implant and biomaterial products, endodontic, orthodontic and orthopedic products. The Global Technology segment focuses on development and distribution of practice management software, e-services, and other products, which are distributed to health care providers. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY. |
| URL | http://www.henryschein.com |
| Investor Relations URL | https://investor.henryschein.com |
| HQ State/Province | New York |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 03, 2026 (est.) |
| Last Earnings Release | Aug. 04, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the following segments: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. The Global Distribution and Value-Added Services segment focuses on distribution to the global dental and medical markets of national brand and corporate brand merchandise, and equipment and related technical services. The Global Specialty Products segment includes manufacturing, marketing and sales of dental implant and biomaterial products, endodontic, orthodontic and orthopedic products. The Global Technology segment focuses on development and distribution of practice management software, e-services, and other products, which are distributed to health care providers. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY. |
| URL | http://www.henryschein.com |
| Investor Relations URL | https://investor.henryschein.com |
| HQ State/Province | New York |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 03, 2026 (est.) |
| Last Earnings Release | Aug. 04, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |